Strategic M&A Signals Recent asset sale to Prime Toxicology and transition of Polytech LIS indicates a potential market shift and partner alignment opportunity. Engage Prime Toxicology or similar lab networks for upsell of integration capabilities with LIS, HIS, EMR, and Billing systems to maintain interoperability and data flow.

Global Reach Opportunity LIS deployments in seven countries present a track record of international scalability. Target expansion into additional regions with similar regulatory and interoperability needs, leveraging existing integrations and customizable workflows to address varied laboratory requirements.

Tech Stack Synergy Current tech footprint includes Oracle Cloud, WordPress, Google Workspace and various integration-focused tools. Position enhancements around cloud-based, secure data exchange, automated reporting, and interoperability with reference labs and practice management ecosystems to attract new clients seeking robust integration.

Midmarket Growth Potential Revenue range and small company size suggest opportunities to upsell to midtier labs or regional lab networks seeking scalable LIS solutions with strong customization. Develop tiered packages that add automation, analytics, and streamlined billing/PM integrations for higher-value contracts.

Sales Enablement Gap New Marketing Director appointment signals a chance to collaborate on targeted campaigns and messaging. Align outreach around interoperability, patient safety improvements, cost reductions, and rapid deployment to capture labs evaluating switching vendors during market changes.